| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/05/2009 | EP1531803A4 Method of inhibiting prostate cancer cell proliferation |
| 08/05/2009 | EP1490038B1 Hybrid system for solubilizing pharmaceutically active substances in polymer matrices |
| 08/05/2009 | EP1430085B1 Leukocyte inactivation module |
| 08/05/2009 | EP1420681A4 Peptide-based multimeric targeted contrast agents |
| 08/05/2009 | EP1367997B1 Injectable water-in-oil emulsions |
| 08/05/2009 | EP1286703B1 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 08/05/2009 | EP1286662A4 Tablets and methods for modified release of hydrophilic and other active agents |
| 08/05/2009 | EP1274402B1 Pharmaceutical composition for the controlled release of paracetamol |
| 08/05/2009 | EP1253939B1 In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete atp binding domain and is cd4+ t cell-independent |
| 08/05/2009 | EP1235595B1 Integrin-mediated drug targeting |
| 08/05/2009 | EP1065936B1 Encapsulation of components into edible products |
| 08/05/2009 | EP0819004B1 Pharmaceutical composition containing proton pump inhibitors |
| 08/05/2009 | CN101501108A Micelles for drug delivery |
| 08/05/2009 | CN101500991A Lipoic acid derivatives |
| 08/05/2009 | CN101500937A Particles for delivery of active ingredients, process of making and compositions thereof |
| 08/05/2009 | CN101500615A A conjugate of an antibody against CCR5 and an antifusogenic peptide |
| 08/05/2009 | CN101500614A Method for making polyethylene glycol carbonates |
| 08/05/2009 | CN101500613A A novel lactic acid formulation of MK-0457 useful for the treatment of cancer |
| 08/05/2009 | CN101500612A Novel formulations which stabilize and inhibit precipitation of immunogenic compositions |
| 08/05/2009 | CN101500584A Use of micron sulfur in prevention and treatment for pathogenic disorder of human or animal |
| 08/05/2009 | CN101500572A Solid compositions comprising tadalafil and at least one carrier |
| 08/05/2009 | CN101500571A Stable lyophilized preparation |
| 08/05/2009 | CN101500570A Novel tape preparation |
| 08/05/2009 | CN101500544A Pharmaceutical formulations and compositions of a selective antagonist of either CXCR2 or both CXCR1 and CXCR2 and methods of using the same for treating inflammatory disorders |
| 08/05/2009 | CN101500541A Process for production of spherical granule containing slightly water-soluble substance |
| 08/05/2009 | CN101497878A Polypeptide of specific efficient affinity membrane type I substrate metal protease (MT1-MMP), protein and use |
| 08/05/2009 | CN101497671A Hydroxyalkyl starch derivatives |
| 08/05/2009 | CN101496903A Coating solution of medicament for reducing stimulation of medicament to stomach |
| 08/05/2009 | CN101496902A Allergen protecting agent |
| 08/05/2009 | CN101496901A Application of acidic buffer in stable pollen allergen activity |
| 08/05/2009 | CN101496863A Chinese medicinal composition for treating anypnia and preparation method thereof |
| 08/05/2009 | CN101496858A Chinese medicinal composition for treating insomnia and preparation method thereof |
| 08/05/2009 | CN101496857A Blood-activating, stasis-resolving, qi-regulating and analgesic dropping pill and preparation method thereof |
| 08/05/2009 | CN101496856A Proanthocyanidin chewing tablet |
| 08/05/2009 | CN101496853A Qi-benefitting, yin-nourishing, blood circulation-promoting and apophlegmatic dropping pill and preparation method thereof |
| 08/05/2009 | CN101496837A 'Relingqing' chewable tablet and preparation method thereof |
| 08/05/2009 | CN101496833A Liquid external preparation for preparing total alkaloids in nux vomica |
| 08/05/2009 | CN101496818A Kidney-nourishing and bone-tonifying chewable tablet and preparation method thereof |
| 08/05/2009 | CN101496813A Anti-hyperblastosis (vascular restenosis) composition and application method |
| 08/05/2009 | CN101496808A Compound xanthophyll microcapsule for sight protection and preparation method thereof |
| 08/05/2009 | CN101496807A Medicament composition with function for protecting liver and reducing enzyme activity |
| 08/05/2009 | CN101496797A Salvianolic acid A phospholipid complexes and preparation method thereof |
| 08/05/2009 | CN101496796A Composite soft capsule of lycopene |
| 08/05/2009 | CN101496795A Biodegradable composite controlled release membrane of medicament and technique for preparing the same |
| 08/05/2009 | CN101496793A Sustained-release matrix tablets and preparation method thereof |
| 08/05/2009 | CN101496792A Punailuoer or delayed-release preparation of salt thereof and preparation method thereof |
| 08/05/2009 | CN101496791A Cefixime sustained-release tablets and preparation method thereof |
| 08/05/2009 | CN101496790A Acarbose chewable tablet |
| 08/05/2009 | CN101496789A Sitafloxacin sustained-release pellet and preparation method thereof |
| 08/05/2009 | CN100523002C Chitin/polydioxide cyclohexanone graft copolymer and its production |
| 08/05/2009 | CN100522998C Method of stabilizing antibody and stabilized solution-type antibody preparation |
| 08/05/2009 | CN100522966C Hydroxycucurbituril derivatives, their preparation methods and uses |
| 08/05/2009 | CN100522962C 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| 08/05/2009 | CN100522338C Encapsulated agglomeration of microcapsules and method for the preparation thereof |
| 08/05/2009 | CN100522249C Elogated and multiple spacers in activatible prodrugs |
| 08/05/2009 | CN100522248C Stable liquid compound fibrillarin blocking agent, and its preparation and use |
| 08/05/2009 | CN100522247C Injectable temperature-sensitive chitosan/methyl cellulose gel and its preparation process |
| 08/05/2009 | CN100522246C Chitosan pellet/microsac and preparation thereof |
| 08/05/2009 | CN100522245C Compositions for transmucosal drug delivery and cryoprotection |
| 08/05/2009 | CN100522244C High viscosity liquid controlled delivery system |
| 08/05/2009 | CN100522243C Animal skin penetrant |
| 08/05/2009 | CN100522239C Pharmaceutical formulations for sustained drug delivery |
| 08/05/2009 | CN100522200C Pills for preventing osteoproliferation and preparing method thereof |
| 08/05/2009 | CN100522173C Pharmaceutical composition containing pemetrexed |
| 08/05/2009 | CN100522165C Lansoprazole intestine solution capsule and its preparation method |
| 08/05/2009 | CN100522163C Small volume vincamine injection and its preparation process |
| 08/05/2009 | CN100522148C Inclusion cyclodextrin/vanillin ex polar bear medicinal composition and its preparing method |
| 08/05/2009 | CN100522145C Preparation process of nano drug-loaded biological micro-capsule |
| 08/05/2009 | CN100522142C Control of process humidify to produce large porous particles |
| 08/04/2009 | US7569706 Chemically modifying a physiologically active polypeptide; improving the stability or water solubility |
| 08/04/2009 | US7569674 Autophilic antibodies |
| 08/04/2009 | US7569643 Chain extended or crosslinked polyethylene oxide/polypropylene oxide/polyethylene oxide block copolymers; polyesterether copolymers; reducing adhesions subsequent to surgery or medical procedure; low viscosity at room temperature; high viscosity at high temperature |
| 08/04/2009 | US7569557 Compositions of estrogen-cyclodextrin complexes |
| 08/04/2009 | US7569556 Fluoroquinolone antibiotic such as ofloxacin, and chemically modified polysaccharide such as oxidized starch reaction product; time release adjuvant solution |
| 08/04/2009 | US7569542 can be produced recombinantly using bacterial, yeast, or eukaryotic cell expression system, without having to deal with problems associated with chemical or physical linkages |
| 08/04/2009 | US7569539 Oral administration of calcitonin |
| 08/04/2009 | US7569387 Specifically binds an MK61 polypeptide produced by immunizing an animal |
| 08/04/2009 | US7569386 Chondroitin synthase gene and methods of making and using same |
| 08/04/2009 | US7569341 Nucleic acid directed immobilization arrays and methods of assembly |
| 08/04/2009 | US7569230 Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof |
| 08/04/2009 | US7569227 Monomeric protein of the TGF-β family |
| 08/04/2009 | US7569214 Hydrolysing water-soluble polyoxyethylene glycol segment having alkoxide ion or thiolate ion with ortho ester comprised of suitable leaving group (methanesulfonate) |
| 08/04/2009 | CA2523987C Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery |
| 08/04/2009 | CA2462606C Orally administered liquid compositions comprising guaifenesin and a polyoxyalkylene block copolymer |
| 08/04/2009 | CA2424566C Dental care compositions |
| 08/04/2009 | CA2420348C Non-hormonal vaginal contraceptive |
| 08/04/2009 | CA2411047C Stable pharmaceutical solution formulations for pressurised metered dose inhalers |
| 08/04/2009 | CA2392367C Composition and method for treatment of otitis media |
| 08/04/2009 | CA2347447C Buffered compositions for dialysis |
| 08/04/2009 | CA2323090C In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of alzheimer's and prion diseases |
| 08/04/2009 | CA2322745C Method of treating neuroma pain |
| 08/04/2009 | CA2272237C Film coatings and film coating compositions based on dextrin |
| 08/04/2009 | CA2243649C Bioresponsive pharmacologically-active polymers and articles made therefrom |
| 08/04/2009 | CA2194673C A conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 08/03/2009 | WO2006079903A1 Antacid lozenge containing micronized salts |
| 08/03/2009 | CA2595984A1 Antacid lozenge containing micronized salts |
| 07/30/2009 | WO2009094459A1 Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief |
| 07/30/2009 | WO2009094340A2 Omentum and use thereof |
| 07/30/2009 | WO2009094209A1 Oligomer-diarylpiperazine conjugates |
| 07/30/2009 | WO2009093713A1 Peg-modified hydroxyapatite, pharmaceutical preparation containing the same as base material, and method for production of the same |